HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

G 1617

structure in first source

Also Known As:

1,2-dihydroisoquinoline; dihydroisoquinoline

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoquinolines: 34
      - G 1617: 3

Experts

1.	Alvarez, Francisco N: 1 article (01/2009)
2.	Carlson, Louise M: 1 article (01/2009)
3.	Lee, Kelvin P: 1 article (01/2009)
4.	Lindner, Inna: 1 article (01/2009)
5.	Hatanaka, Toshiki: 1 article (01/2007)
6.	Miyata, Keiji: 1 article (01/2007)
7.	Noguchi, Yukiko: 1 article (01/2007)
8.	Ohtake, Akiyoshi: 1 article (01/2007)
9.	Okutsu, Hiroko: 1 article (01/2007)
10.	Saitoh, Chikashi: 1 article (01/2007)

Related Diseases

1.	Overactive Urinary Bladder (Overactive Bladder) 01/01/2007 - "Solifenacin succinate [YM905; (3R)-1-azabicyclo[2.2.2]oct-3-yl(1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate monosuccinate] is a new muscarinic receptor antagonist developed for the treatment of overactive bladder. "
2.	Measles 12/01/2003 - "In an effort to develop therapies to supplement immunization strategies a number of 1-oxo-2-[[(1E)-phenylmethylene]amino]-1,2-dihydroisoquinoline-4-carboxylic acid derivatives were synthesized and evaluated for anti-measles activity. "
3.	Breast Neoplasms (Breast Cancer) 01/01/2009 - "6,7-dihydroxy-3,4-dihydroisoquinoline: a novel inhibitor of nuclear factor-kappaB and in vitro invasion in murine mammary cancer cells."

Related Drugs and Biologics

1.	NF-kappa B (NF-kB)
2.	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)
3.	Carboxylic Acids
4.	Solifenacin Succinate

Related Therapies and Procedures

1.	Therapeutics